Back to search

Article

Gallic acid enhances the antitumor activity of Icotinib hydrochloride in non-small cell lung cancer via of Hippo-YAP signaling pathway in vitro and in vivo

2022-01-28

Abstract excerpt

<title>Abstract</title> <p>Icotinib hydrochloride (IH) is a small molecular TKI independently developed in China. As the first-line anti-tumor agent, is widely used for treatment of non-small cell lung cancer (NSCLC). Gallic acid (GA), a natural plant extract, is reported that it has a variety of pharmacological and biological properties. GA is a active natural phenolic extracted from Tannins that has been shown...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6a707555-4b2b-5801-8a6b-2fa31498fb14
DOI
10.21203/rs.3.rs-1217354/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Gallic acid enhances the antitumor activity of Icotinib hydrochloride in non-small cell lung cancer via of Hippo-YAP signaling pathway in vitro and in vivoDOI 10.21203/rs.3.rs-1217354/v1
The in Vitro and in Vivo Antitumor Effect Associating With the Hippo-yap Signaling Pathway of Gallic Acid and Its Combination With Icotinib Hydrochloride on the Non-small Cell Lung Cancer Cellular and Xenograft Tumor-bearing Nude Mouse ModelsSemantic proximity
[Expert consensus on icotinib as adjuvant therapy for non-small cell lung cancer].Semantic proximity
Efficacy and influence factors of icotinib hydrochloride in treating advanced non-small cell lung cancer.Semantic proximity
The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study.Semantic proximity
Natural Compound Library Screening Identifies Sanguinarine Chloride For The Treatment of SCLC By Upregulating CDKN1ASemantic proximity
[Clinical Observation of Icotinib Hydrochloride for Advanced Non-small Cell Lung Cancer Patients with EGFR Status Identified].Semantic proximity
Efficacy and safety of icotinib in treating non-small cell lung cancer: a systematic evaluation and meta-analysis based on 15 studies.Semantic proximity
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models.Semantic proximity
α-Tomatine Inhibits Proliferation, Metastasis, Drug Resistance and Immune Infiltration Through the PI3K-AKT-MAPK Axis in Gastric CancerSemantic proximity
Retrospective analysis of icotinib neoadjuvant therapy of 63 lung cancer patients.Semantic proximity
Alpha-Solanine Anti-Tumor Effects in Non-Small Cell Lung Cancer Through Regulating the Glycolysis PathwaySemantic proximity
Epigallocatechin gallate circumvents drug-induced resistance in non-small-cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis.Semantic proximity
Select a neighboring publication to make it the new centre.